Germany / Bayer’s Stellar 2021; Vaccine Supplies Until 2029; BioNTech/Regeneron Cancer Partnership
The latest from German pharma, including Bayer’s 2021 financial results, the country’s plan to spend $3.14 billion on vaccine capacity to cover Covid-19 outbreaks until 2029, and Boehringer Ingleheim’s case…